Evidence map›Paper›PMID 42395369›Full record

ArticlebioRxiv : the preprint server for biology2026

Ambiguity-Aware Multi-Stage Cell-Type Annotation for Spatial Transcriptomics.

Md Ishtyaq Mahmud, Veena Kochat, Humaira Anzum, Suresh Satpati, Jagan Mohan Reddy Dwarampudi, Kunal Rai, Tania Banerjee

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Md Ishtyaq MahmudDepartment of Electrical and Computer Engineering, University of Houston, Houston, TX 77004, USA.ORCID 0000-0001-6280-7035
Veena KochatDepartment of Genomic Medicine and MDACC Epigenomics Therapy Initiative (METI), MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0003-2614-3790
Humaira AnzumDepartment of Electrical and Computer Engineering, University of Houston, Houston, TX 77004, USA.ORCID 0009-0004-4779-8125
Suresh SatpatiDepartment of Genomic Medicine and MDACC Epigenomics Therapy Initiative (METI), MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-8988-6113
Jagan Mohan Reddy DwarampudiDepartment of Electrical and Computer Engineering, University of Houston, Houston, TX 77004, USA.ORCID 0009-0006-2947-4164
Kunal RaiDepartment of Genomic Medicine and MDACC Epigenomics Therapy Initiative (METI), MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0003-2321-6894
Tania BanerjeeDepartment of Information Science Technology, University of Houston, Sugar Land, TX 77479, USA.ORCID 0000-0003-4737-0001

Funding

Consortium for Translational and Precision HealthUM1TR004539 · NCATS · BAYLOR COLLEGE OF MEDICINE · PI Bettina M. Beech, FASIHA KANWAL · 2024 to 2026
$17.1M
NCATS NIH HHS UM1 TR004539
6 · The paper itself

Abstract

Spatial transcriptomics enables characterization of cellular organization in intact tissue, but robust cell-type annotation remains challenging due to heterogeneous expression profiles, mixed populations, and transitional states. Existing methods often enforce a single label per cluster, obscuring biologically meaningful ambiguity and producing overconfident assignments. We propose an ambiguity-aware, multi-stage framework for spatial cell-type annotation. The method combines hybrid spatial-feature clustering with constrained language-model inference over curated label sets, and assigns confidence scores based on marker coverage, candidate separation, and entropy. Low-confidence clusters are selectively refined via local reclustering of ambiguous regions, while unresolved clusters are preserved as mixed rather than forcibly labeled. Applied to 10x Genomics Xenium spatial transcriptomics data from cholangiocarcinoma, the proposed refinement reduces cluster-level ambiguity from 16.1% to 2.27% and cell-level ambiguity from 18.4% to 0.86%, while improving confidence calibration. Spatial ablation confirms that topological integration resolves structural ambiguity over feature-only baselines, while constrained inference via a lightweight language model ensures scalable and biologically coherent annotations. These results highlight the importance of explicit ambiguity handling for reliable spatial annotation in heterogeneous tumors.

Indexed as

Ambiguity-aware cell annotationMulti-stage inferenceSpatial transcriptomics

Identifiers

PMID42395369
PMCPMC13320773

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.